Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hall

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Journal of the American Heart Association|November 28, 2023
Efficacy and Adherence Rates of a Novel Community-Informed Virtual World-Based Cardiac Rehabilitation Program: Protocol for the <i>Destination Cardiac Rehab</i> Randomized Controlled TrialLaPrincess C Brewer, Helayna Abraham, Donald Clark, et al.
Diabetologia|December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertensionJohn P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2006
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y Saulter, Etsuko Usuki, et al.
Plos One|December 5, 2012
Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 DiabetesRandy Hecht, Yue-Sheng Li, Jeonghoon Sun, et al.
Trials|October 26, 2024
Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural MadagascarEmmanuelle Sandra Adjoa Ametepe, Noela Andriamanoha, Fanantenana Randria Andrianomanana, et al.
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
JACC. Basic to Translational Science|September 17, 2025
SECTM1 Regulates Monocyte Levels and Is Associated With Incident Coronary Heart DiseaseUsman A Tahir, Daniel Cruz, Dongxiao Shen, et al.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Australian and New Zealand Journal of Public Health|September 19, 2022
Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre studyPeter Miller, Thea Vakidis, Nicholas Taylor, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Journal of the American Heart Association|November 28, 2023
Efficacy and Adherence Rates of a Novel Community-Informed Virtual World-Based Cardiac Rehabilitation Program: Protocol for the <i>Destination Cardiac Rehab</i> Randomized Controlled TrialLaPrincess C Brewer, Helayna Abraham, Donald Clark, et al.
Diabetologia|December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertensionJohn P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 26, 2006
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y Saulter, Etsuko Usuki, et al.
Plos One|December 5, 2012
Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 DiabetesRandy Hecht, Yue-Sheng Li, Jeonghoon Sun, et al.
Trials|October 26, 2024
Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural MadagascarEmmanuelle Sandra Adjoa Ametepe, Noela Andriamanoha, Fanantenana Randria Andrianomanana, et al.
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
JACC. Basic to Translational Science|September 17, 2025
SECTM1 Regulates Monocyte Levels and Is Associated With Incident Coronary Heart DiseaseUsman A Tahir, Daniel Cruz, Dongxiao Shen, et al.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Australian and New Zealand Journal of Public Health|September 19, 2022
Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre studyPeter Miller, Thea Vakidis, Nicholas Taylor, et al.
Pageof 18